Well Differentiated Thyroid Cancer

Kebebew E Clark OH Differentiated thyroid cancer: “complete” rational approach. World J Surg 2000;24:942–951.

Ringel MD Ladenson PW Controversies in the follow-up and management of well-differentiated thyroid cancer. Endocr Relat Cancer 2004;11:97–116.

Busnardo B De Vido D The epidemiology and etiology of differentiated thyroid carcinoma. Biomed Pharmacother 2000; 54: 322–326.

Gow KW Lensing S Hill DA Krasin MJ McCarville MB Rai SN Zacher M Spunt SL Strickland DK Hudson MM Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature. J Pediatr Surg 2003;38:1574–1580.

Hellman P Goretzki P Witte J Roeher H Follicular thyroid cancer. In: Surgical Endocrinology. Eds Doherty G.M. Skogseid B Philadelphia Lippincott Williams & Wilkins 2001 pp. 75–86.

D'Avanzo A Treseler P Ituarte PH Wong M Streja L Greenspan FS Siperstein AE Duh QY Clark OH Follicular thyroid carcinoma: Histology and prognosis. Cancer 2004;100:1123–1129.

Segev DL Umbricht C Zeiger MA Molecular pathogenesis of thyroid cancer. Surg Oncol 2003;12:69–90.

Tallini G Molecular pathobiology of thyroid neoplasms. Endocr Pathol 2002;13:271–288.

Kebebew E Clark OH Papillary thyroid cancer. In: Surgical Endocrinology. Eds Doherty G.M. Skogseid B Philadelphia Lippincott Williams & Wilkins 2001 pp. 59–74.

Zidan J Karen D Stein M Rosenblatt E Basher W Kuten A Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival. Cancer 2003;97:1181–1185.

Carcangiu ML Zampi G Rosai J Papillary thyroid carcinoma: A study of its many morphologic expressions and clinical correlates. Pathol Annu 1985;20:1–44.

LiVolsi VA Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival. Cancer 2003; 98: 1997; author reply 1997–1998.

Grossman RF Clark OH Hurthle cell carcinoma. Cancer Control 1997;4:13–17.

Karam M Gianoukakis A Feustel PJ Cheema A Postal ES Cooper JA Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nucl Med Commun 2003;24:489–495.

Mazzaferri EL Jhiang SM Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418–428.

Angelos P Current approaches to the treatment of well-differentiated thyroid cancer. Oncology (Huntingt) 2002; 16: 309–315; discussion 315, 318, 323–304.

McGriff NJ Csako G Gourgiotis L Lori CG Pucino F Sarlis NJ Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 2002;34:554–564.

Ford D Giridharan S McConkey C Hartley A Brammer C Watkinson JC Glaholm J External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 2003;15:337–341.

Zarnegar R Brunaud L Kanauchi H Wong M Fung M Ginzinger D Duh QY Clark OH Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor. Surgery 2002; 132: 984–990; discussion 990.

Park JW Clark OH Redifferentiation therapy for thyroid cancer. Surg Clin North Am 2004;84:921–943.

Mazzaferri EL Robbins RJ Spencer CA Braverman LE Pacini F Wartofsky L Haugen BR Sherman SI Cooper DS Braunstein GD Lee S Davies TF Arafah BM Ladenson PW Pinchera A A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433–1441.

Khan N Oriuchi N Higuchi T Zhang H Endo K PET in the follow-up of differentiated thyroid cancer. Br J Radiol 2003;76:690–695.

Lind P Kresnik E Kumnig G Gallowitsch HJ Igerc I Matschnig S Gomez I 18F-FDG-PET in the follow-up of thyroid cancer. Acta Med Austriaca 2003;30:17–21.

Chin BB Patel P Cohade C Ewertz M Wahl R Ladenson P Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 2004;89:91–95.